Fingerprint
Dive into the research topics of 'Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon
R. Katherine Alpaugh, Margaret Von Mehren, Irma Palazzo, Michael B. Atkins, Joseph A. Sparano, Lynn Schuchter, Louis M. Weiner, Janice P. Dutcher
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations